Beit Jala Pharmaceutical Company (PEX:BJP)
Palestine · Delayed Price · Currency is JOD 3.620
0.00 (0.00%)
At close: Jan 13, 2026
PEX:BJP Revenue
Beit Jala Pharmaceutical Company had revenue of 2.83M JOD in the quarter ending September 30, 2025, with 24.18% growth. This brings the company's revenue in the last twelve months to 12.05M, up 32.68% year-over-year. In the year 2024, Beit Jala Pharmaceutical Company had annual revenue of 9.66M with 0.54% growth.
Revenue (ttm)
12.05M
Revenue Growth
+32.68%
P/S Ratio
2.10
Revenue / Employee
54.05K
Employees
214
Market Cap
25.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.66M | 51.85K | 0.54% |
| Dec 31, 2023 | 9.61M | -1.16M | -10.73% |
| Dec 31, 2022 | 10.77M | 1.01M | 10.37% |
| Dec 31, 2021 | 9.76M | 1.07M | 12.26% |
| Dec 31, 2020 | 8.69M | -124.67K | -1.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition